SyedMoinuddinJilaniMD

Oncology • Torrance, CA

Clinical Investigator at Science 37, Inc.

Join to view full profile

Dr. Jilani is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jilani's full profile

Already have an account?

Office
3285 Skypark Dr
Torrance, CA 90505
Phone+1 310-750-3300

Fax+1 310-750-3381

Clinical Expertise

Medical oncology, Hematology, Hematologic oncology

Education & Training

UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1995 - 1998
University of Missouri-ColumbiaResidency, Internal Medicine, 1993 - 1995
University of Missouri-ColumbiaInternship, Internal Medicine, 1992 - 1993
Aga Khan Medical CollegeClass of 1984, Bachelor of Medicine and Surgery (M.B.B.S.)

Certifications & Licensure

CA State Medical License 1995 - 2026
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Study to Assess the Effectiveness of RCHOP With or Without VELCADE in Previously Untreated Non-Germinal Center B-Cell-like Diffuse Large B-Cell Lymphoma Patients Start of enrollment: 2009 Oct 01
Completed
Phase 2
A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC Start of enrollment: 2013 Apr 01
Terminated
Phase 3
A Phase 2, Study of Ficlatuzumab Plus Erlotinib vs. Placebo Plus Erlotinib in Subjects With Previously Untreated Metastatic, EGFR-mutated NSCLC and BDX004 Positive Label Start of enrollment: 2014 Nov 01
Terminated
Phase 2

Publications & Presentations

PubMed

1 citations
The spectrum of neurological complications in Pakistani patients with malignancies.
Asif Sharfuddin, Hala Fatima, Syed M Jilani, Farah H. Mozaffar, Tahseen Mozaffar
JPMA. the Journal of the Pakistan Medical Association. 2008-04-01

Press Mentions

How I Found (And Trusted) My Doctor for Skin Cancer as a Person of ColorMay 23rd, 2023
Safety and Efficacy of Telatinib in Combination with Keytruda in Subjects with Advanced Stomach and Gastroesophageal Junction Cancers or Hepatocellular CarcinomaMarch 15th, 2021

Professional Memberships

American Society of Clinical Oncology - ASCO
Member
American Medical Association - AMA
Member
Los Angeles County Medical Association
Member
Medical Oncology Association of Southern California
Member
Southern California Academy of Clinical Oncology
Member

External Links

Science 37, Inc.http://www.science37.com/